Postdoctoral Researcher - Mathematical/Computational Biology

We are seeking an exceptional, enthusiastic and motivated scientist possessing doctoral, and preferably postdoctoral, experience in mathematics, applied mathematics or computational modelling, with the ability to work to a high standard. Previous research experience, attention to detail and an ability to work both independently and as part of a team are essential.

Clinical Trial Administrator

We have an exciting opportunity available for a Clinical Trial Administrator to join the Oncology Clinical Trials Office (OCTO) in the Department of Oncology, as part of a team running a portfolio of early phase clinical trials and studies, in different tumour types and therapeutic areas. OCTO runs academic clinical trials to the highest standards and is proactive in improving clinical trial procedures and delivering high quality data.

Quality Assurance Administrator

This is a quality assurance (QA) administrator position to oversee document control, asset management, training records, internal auditing and other activity required for GCP compliance. The postholder will support the running and maintenance of the Translational Histopathology Laboratory (THL) Quality Management System (QMS) for assurance of GCP compliance. They will also coordinate the production and approval of local SOPs that are required for the effective running of the THL, including writing and reviewing protocols and risk assessments.

Clinical Research Fellow

This fellowship is being offered by the Department of Oncology, for a clinician wishing to undertake a clinical DPhil. The purpose of the fellowship is to allow an oncologist to pursue clinical academic research in device-enhanced oncological drug delivery.

Postdoctoral Researcher - Synthetic Chemist/PET Radiochemist

An exciting opportunity is available for a Postdoctoral Researcher to join the Department of Oncology. You will contribute to the research of the Radiopharmacy and Molecular Imaging Group, led by Professor Bart Cornelissen, in collaboration with Dr Rebekka Hueting, Head of the radiochemistry/radiopharmacy core group by undertaking research into the development of radiolabelled agents for imaging of DNA damage in vitro and in vivo using PET imaging and in doing so, contribute to the Groups aim of the development of novel radiolabelled imaging agents for oncology


About Us
We aim to enhance clinical and basic cancer research in Oxford with the ultimate goal of increasing cancer cure rates.
In Oxford, we have a great wealth of broad-ranging expertise and a powerful network of cancer researchers.
Study With Us
Our graduate training programmes for both scientists and clinicians are internationally recognised.
Subscribe to Department of Oncology RSS